Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Net Cash Flow (2021 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Net Cash Flow came in at $24.5 million in Q1 2026, up 1086.51% YoY from $2.1 million in Q1 2025, and down 71.84% on a QoQ basis from $87.0 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Net Cash Flow (2021 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 6 years of Net Cash Flow data on file, last reported at $24.5 million in Q1 2026.

  • Quarterly Net Cash Flow rose 1086.51% year-over-year to $24.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $118.0 million (up 1705.97% YoY) and the FY2025 annual result came in at $13.5 million, up 282.71% from the prior year.
  • Net Cash Flow declined to $24.5 million in Q1 2026, from $87.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $87.0 million in Q4 2025 to a low of -$3.1 million in Q3 2024.
  • A 5-year average of $7.0 million and a median of -$1.1 million in 2022 frame the typical range for Net Cash Flow.
  • Annual changes were most pronounced in 2022 — Net Cash Flow slumped 24095.05% — and 2025, when it jumped 7272.57%.
  • Tracing CNTN's Net Cash Flow over 5 years: stood at -$1.1 million in 2022, then soared by 859.23% to $8.2 million in 2023, then plunged by 114.71% to -$1.2 million in 2024, then jumped by 7272.57% to $87.0 million in 2025, then plunged by 71.84% to $24.5 million in 2026.
  • The last three Net Cash Flow figures came in at $24.5 million (Q1 2026), $87.0 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - -3.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.71 Mn
Mar 31, 2026 24.50 Mn
Dec 31, 2025 87.01 Mn
Sep 30, 2025 5.36 Mn
Jun 30, 2025 1.17 Mn
Mar 31, 2025 -2.48 Mn
Dec 31, 2024 -1.21 Mn
Sep 30, 2024 -3.12 Mn
Jun 30, 2024 -531,463.00
Mar 31, 2024 -2.51 Mn
Dec 31, 2023 8.25 Mn
Sep 30, 2023 -1.21 Mn
Jun 30, 2023 334,825.00
Mar 31, 2023 -2.94 Mn
Dec 31, 2022 -1.09 Mn
Sep 30, 2022 -1.89 Mn
Jun 30, 2022 -1.64 Mn
Mar 31, 2022 11.12 Mn
Dec 31, 2021 -40,739.00
Sep 30, 2021 15,824.00